21.7 C
Dubai
Friday, March 6, 2026
- Advertisement -spot_img

TAG

tl1a

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting TL1ADuvakitug is currently in phase 3...

Latest news

- Advertisement -spot_img